ArticleEJHaem2026

Mogamulizumab as Bridge to Thiotepa-Based Allogeneic Haematopoietic Stem Cell Transplantation in Sézary Syndrome: A Single-Centre Experience.

Simone Maifredi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.